# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-22-020459
Filing Date
2022-04-19
Accepted
2022-04-19 06:01:43
Documents
4
Period of Report
2022-06-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | def14a0422_inmunebio.htm | DEF 14A | 922503
2 | GRAPHIC | tinmunebio_logo.jpg | GRAPHIC | 89408
3 | GRAPHIC | tproxy_001.jpg | GRAPHIC | 939211
4 | GRAPHIC | tproxy_002.jpg | GRAPHIC | 790898
| Complete submission text file | 0001213900-22-020459.txt |  | 3430311

Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38793 | Film No.: 22833378
SIC: 2836 Biological Products, (No Diagnostic Substances)